These side effects had been notably milder compared to an inhibitor of each bromodomains. An in depth molecular Assessment also disclosed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor - "Our study disclosed the critical role with the KLF16/MYC regulatory axis in modulating tumor https://abbv-744-in-acute-myeloid36812.like-blogs.com/31791868/the-best-side-of-abbv-744-clinical-trial-phase-2-data